ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 156 filers reported holding ANIKA THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $57,462,000 | +15.8% | 1,173,660 | +13.2% | 0.01% | +10.0% |
Q3 2016 | $49,601,000 | -2.0% | 1,036,596 | +9.9% | 0.01% | -9.1% |
Q2 2016 | $50,608,000 | +21.6% | 943,296 | +1.3% | 0.01% | +10.0% |
Q1 2016 | $41,626,000 | +14.5% | 930,806 | -2.3% | 0.01% | +25.0% |
Q4 2015 | $36,356,000 | +25.7% | 952,731 | +4.8% | 0.01% | +14.3% |
Q3 2015 | $28,933,000 | +0.0% | 908,994 | +3.8% | 0.01% | 0.0% |
Q2 2015 | $28,921,000 | -21.3% | 875,608 | -1.9% | 0.01% | -22.2% |
Q1 2015 | $36,748,000 | +8.4% | 892,596 | +7.3% | 0.01% | +12.5% |
Q4 2014 | $33,890,000 | +22.1% | 831,857 | +9.9% | 0.01% | 0.0% |
Q3 2014 | $27,747,000 | -13.4% | 756,885 | +9.4% | 0.01% | -11.1% |
Q2 2014 | $32,042,000 | +16.6% | 691,614 | +3.4% | 0.01% | +12.5% |
Q1 2014 | $27,481,000 | +9.0% | 668,627 | +1.2% | 0.01% | 0.0% |
Q4 2013 | $25,210,000 | +209.7% | 660,637 | +93.9% | 0.01% | +166.7% |
Q3 2013 | $8,141,000 | +58.0% | 340,762 | +12.4% | 0.00% | +50.0% |
Q2 2013 | $5,154,000 | – | 303,157 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |